focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

Mon, 09th May 2022 14:01

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

The AIM-traded firm said Kestrel Partners, on behalf of its discretionary clients, bought 27,129 shares for 150p each, spending a total of £40,693.50.

Its non-executive director Oliver Scott is a partner of, and holds a beneficial interest in Kestrel, and is also a shareholder in one of Kestrel's clients, Kestrel Opportunities, and so has a beneficial interest in Kestrel Opportunities' entire legal holding in the company.

Following the purchase, K3 said Kestrel Opportunities held 8,515,879 of its shares, and other clients of Kestrel in which Scott had no beneficial interest held 2,775,101 shares.

In total, Kestrel indirectly held voting rights over 11,290,980 of K3's shares, representing 25.24% percent of its issued share capital.

On the selling side of the ledger, specialty pharmaceutical company Diurnal Group disclosed a sale worth over £40k made by its chief scientific officer.

The AIM-traded firm said Richard Ross sold 312,000 shares for 13p each, while his and his wife's individual savings accounts (ISAs) purchased 153,500 and 153,500 shares, respectively, at a price of 13.01p each.

Following the transactions, the total beneficial interest of Richard Ross and his connected parties was 2,257,155 shares, representing 1.33% of Diurnal's total voting rights as of 9 May.

Top Director Buys

K3 Business Technology Group (KBT)

Director name: Scott,Oliver Rupert Andrew

Amount purchased: 27,129 @ 150.00p

Value: £40,693.50

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Discoverie Group (DSCV)

Director name: Watson ,Clive

Amount purchased: 2,875 @ 690.00p

Value: £19,837.50

Henderson Smaller Companies Inv Trust (HSL)

Director name: Carter,Kevin

Amount purchased: 1,500 @ 868.36p

Value: £13,025.39

Target Healthcare Reit Ltd (THRL)

Director name: Fyfe,Alison

Amount purchased: 10,000 @ 109.80p

Value: £10,980.00

Mgc Pharmaceuticals Limited Npv (di) (MXC)

Director name: Zomer,Roby

Amount purchased: 819,672 @ 1.30p

Value: £10,655.74

Parity Group (PTY)

Director name: Johns,Mike

Amount purchased: 139,082 @ 7.19p

Value: £10,000.00

Mondi (MNDI)

Director name: Strank,Angela

Amount purchased: 628 @ 1,579.95p

Value: £9,922.08

Henderson Smaller Companies Inv Trust (HSL)

Director name: Freer,Penelope Anne

Amount purchased: 1,000 @ 878.92p

Value: £8,789.20

Reach (RCH)

Director name: Panayi,Barry

Amount purchased: 3,979 @ 124.72p

Value: £4,962.77

Capita (CPI)

Director name: Murphy,Joseph

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Lewis,Jonathan (Jon)

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Weller,Tim

Amount purchased: 643 @ 26.83p

Value: £172.52

Assura (AGR)

Director name: Cottam,Jayne

Amount purchased: 228 @ 66.16p

Value: £150.84

Assura (AGR)

Director name: Murphy,Jonathan

Amount purchased: 228 @ 66.16p

Value: £150.84

Top Director Sells

Rolls-royce Holdings (RR.)

Director name: East,Warren

Amount sold: 210,515 @ 83.78p

Value: £176,369.47

Diurnal Group (DNL)

Director name: Ross,Richard

Amount sold: 312,000 @ 13.00p

Value: £40,560.00

More News
25 Jul 2018 09:39

IP Group Swings To Loss In First-Half On Reduction In Portfolio Gains

LONDON (Alliance News) - IP Group PLC on Wednesday said it saw a swing to loss in the first half of 2018 despite an improvement in its portfolio valuation.The intellectual property-based to

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
3 Apr 2018 16:19

Diurnal To Raise GBP10.5 Million Via Share Placing (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said on Tuesday that it intends to raise GBP10.5 million through the placing of different types of shares.The

Read more
20 Mar 2018 18:28

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 in

Read more
12 Mar 2018 13:51

UPDATE: Diurnal Prepares For First Revenue As Appoints Trial Partner

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Monday appointed a clinical trial services provider for its Chronocort treatment, as it posted a widened loss

Read more
12 Mar 2018 10:18

Diurnal Interim Loss Widens On Cost Rise As Prepares For First Revenue

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Monday its interim loss widened amid a rise in research and administrative expenses, as it prepares to its

Read more
12 Mar 2018 05:17

UK Stocks-Factors to watch on March 12

March 12 (Reuters) - Britain's FTSE 100 index is seen opening up 8 points higher at 7,233 on Monday, according to financial bookmakers. * GKN-MELROSE: GKN has struck a deal

Read more
25 Jan 2017 09:31

Diurnal Agrees Two Deals With UDG Healthcare Ahead Of Infacort Launch

Read more
17 Jan 2017 15:43

DIRECTOR DEALINGS: Diurnal Non-Executive Ups Interest

Read more
16 Jan 2017 15:08

Director dealings: Diurnal trio dip in after EMA submission in December

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year. Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a pri

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
20 Dec 2016 12:23

Diurnal Submits European Marketing Application For Infacort

Read more
21 Nov 2016 09:32

Diurnal Doses First Testosterone Replacement Therapy Trial Patients

Read more
5 Oct 2016 15:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Jul 2016 08:00

Diurnal and IP Group eye 2017 launch for childhood hormonal treatment

(ShareCast News) - Diurnal Group, 45%-owned by university spin-out specialist IP Group, has produced positive clinical trial results for its treatment for a rare hormonal disease in young children. A European Phase III study for AIM-quoted Diurnal's Infacort treatment for paediatric Adrenal Insuffic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.